Jalota Deepika 4
4 · PMV Pharmaceuticals, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Jalota Deepika
Chief Development Officer
Transactions
- Sale
Common Stock
2025-07-01$1.06/sh−33,065$35,198→ 89,959 total
Footnotes (1)
- [F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.